OpenAlex · Aktualisierung stündlich · Letzte Aktualisierung: 17.03.2026, 00:19

Dies ist eine Übersichtsseite mit Metadaten zu dieser wissenschaftlichen Arbeit. Der vollständige Artikel ist beim Verlag verfügbar.

Artificial Intelligence for Medication Management in Discordant Chronic Comorbidities: An Analysis from Healthcare Provider and Patient Perspectives

2025·1 Zitationen·InformationOpen Access
Volltext beim Verlag öffnen

1

Zitationen

3

Autoren

2025

Jahr

Abstract

Recent advances in artificial intelligence (AI) have created opportunities to enhance medical decision-making for patients with discordant chronic conditions (DCCs), where a patient has multiple, often unrelated, chronic conditions with conflicting treatment plans. This paper explores the perspectives of healthcare providers (n = 10) and patients (n = 6) regarding AI tools for medication management. Participants were recruited through two healthcare centers, with interviews conducted via Zoom. The semi-structured interviews (60–90 min) explored their views on AI, including its potential role and limitations in medication decision making and management of DCCs. Data were analyzed using a mixed-methods approach, including semantic analysis and grounded theory, yielding an inter-rater reliability of 0.9. Three themes emerged: empathy in AI–patient interactions, support for AI-assisted administrative tasks, and challenges in using AI for complex chronic diseases. Our findings suggest that while AI can support decision-making, its effectiveness depends on complementing human judgment, particularly in empathetic communication. The paper also highlights the importance of clear AI-generated information and the need for future research on embedding empathy and ethical standards in AI systems.

Ähnliche Arbeiten

Autoren

Institutionen

Themen

Pharmaceutical Practices and Patient OutcomesArtificial Intelligence in Healthcare and EducationElectronic Health Records Systems
Volltext beim Verlag öffnen